Bayer leads seven Big Pharmas in €196m European Lead Factory
This article was originally published in Scrip
Bayer HealthCare will co-ordinate a €196 million drug discovery project supported by the Innovative Medicines Initiative (IMI), launched on 7 February by an international consortium of 30 partners including six other Big Pharma players.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.